Harrow Balance Sheet
NASDAQ: HROWHealthcareDrug Manufacturers - Specialty & GenericUSD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Harrow financial position
At the end of fiscal 2025, Harrow reported total assets of $399.5 million, up 2.7% from a year earlier against total liabilities of $347.4 million. Shareholders' equity stood at $52.4 million, or 13.1% of assets. The company held $72.9 million in cash and equivalents against $243.2 million of debt, a net debt position of $170.3 million.
The current ratio (current assets divided by current liabilities) was 2.20, meaning short-term assets cover obligations due within a year. Debt-to-equity was 4.64.
Summary generated from market data by MetaCap's automated system. Methodology
Harrow balance sheet (annual)
| Fiscal year (USD) | FY 20252025-12-31 | FY 20242024-12-31 | FY 20232023-12-31 | FY 20222022-12-31 | FY 20212021-12-31 | FY 20202020-12-31 | FY 20192019-12-31 | FY 20182018-12-31 | FY 20172017-12-31 | FY 20162016-12-31 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | 72.93M | 47.25M | 74.08M | 96.27M | 42.17M | 4.10M | 4.75M | 6.84M | 4.02M | 8.85M |
| Short-Term Investments | — | — | 8.68M | 5.59M | 8.50M | 28.45M | — | — | — | — |
| Receivables | 110.89M | 116.37M | 36.26M | 6.25M | 4.47M | 2.66M | 2.01M | 1.91M | 1.53M | 2.92M |
| Inventory | 13.52M | 10.70M | 10.87M | 6.54M | 4.22M | 3.96M | 3.30M | 1.83M | 2.25M | 1.84M |
| Total Current Assets | 211.75M | 189.65M | 139.48M | 118.26M | 60.66M | 40.98M | 36.05M | 32.84M | 8.81M | 14.75M |
| Property, Plant & Equipment | 3.26M | 3.73M | 3.52M | 3.49M | 3.14M | 3.87M | 5.38M | 6.38M | 6.21M | 7.29M |
| Goodwill | 332.00K | 332.00K | 332.00K | 332.00K | 332.00K | 332.00K | 332.00K | 2.23M | 2.23M | 2.23M |
| Intangible Assets | 175.17M | 184.95M | 159.91M | 23.73M | 15.81M | 1.94M | 2.34M | 3.06M | 2.86M | 2.97M |
| Total Assets | 399.48M | 388.97M | 312.16M | 157.38M | 98.33M | 57.47M | 59.09M | 49.45M | 23.92M | 27.25M |
| Accounts Payable | 35.35M | 38.76M | 24.58M | 13.77M | 6.34M | 3.93M | 7.70M | 6.25M | 3.88M | 3.54M |
| Short-Term Debt | — | — | — | — | — | — | — | 720.00K | — | — |
| Total Current Liabilities | 96.30M | 91.34M | 49.34M | 18.63M | 9.72M | 10.80M | 12.28M | 11.90M | 5.77M | 9.90M |
| Long-Term Debt | 243.18M | 219.54M | 185.88M | 104.17M | 71.65M | 12.38M | 12.22M | 12.00M | 14.01M | 7.94M |
| Total Liabilities | 347.39M | 319.67M | 241.75M | 130.14M | 87.40M | 30.65M | 31.67M | 24.70M | 21.30M | 20.82M |
| Shareholders' Equity | 52.45M | 69.65M | 70.77M | 27.59M | 11.29M | 27.18M | 27.71M | 24.75M | 2.62M | 6.43M |
| Retained Earnings | -156.52M | -151.38M | -133.90M | -109.49M | -95.41M | -77.40M | -74.04M | -74.21M | -88.84M | -76.85M |
| Total Debt | 243.18M | 219.54M | 185.88M | 104.17M | 71.65M | 12.38M | 12.22M | 12.72M | 14.01M | 7.94M |
| Net Cash (Debt) | -170.26M | -172.29M | -103.12M | -2.31M | -20.98M | 20.18M | -7.47M | -5.88M | -9.99M | 916.00K |
| Shares Outstanding | 37.23M | 35.62M | 35.17M | 29.90M | 26.90M | 25.75M | 25.53M | 24.34M | 20.62M | 18.63M |
This table shows 10 annual periods of Harrow's balance sheet, from FY 2025 back to FY 2016, across 19 line items including cash & equivalents, short-term investments, receivables. Values in USD; B = billions, M = millions. Fiscal periods follow HROW's reporting calendar. What is a balance sheet?